Some antidepressants can reduce ADHD symptoms, but they are not first-line treatments and generally work less effectively than stimulant medications. No antidepressant currently has FDA approval specifically for ADHD. When they are prescribed, it’s typically off-label, either because stimulants haven’t worked, cause intolerable side effects, or because the person also has depression or anxiety alongside ADHD.
Why Certain Antidepressants Affect ADHD Symptoms
ADHD involves underactivity in brain circuits that rely on two chemical messengers: dopamine and norepinephrine. These chemicals regulate attention, impulse control, and the ability to plan and organize. Stimulant medications like methylphenidate and amphetamines work by boosting both of these chemicals in the prefrontal cortex, the part of the brain responsible for executive function.
Some antidepressants happen to increase the same chemicals, which is why they can improve focus and reduce impulsivity in people with ADHD. Not all antidepressants do this, though. Standard SSRIs (the most commonly prescribed class for depression) primarily raise serotonin levels, which has little direct effect on the core attention and impulse-control deficits in ADHD. The antidepressants that help with ADHD are the ones that also act on dopamine or norepinephrine.
Which Antidepressants Are Used for ADHD
Bupropion
Bupropion is the antidepressant most commonly tried for ADHD because it increases both dopamine and norepinephrine. In a clinical trial comparing bupropion, methylphenidate, and placebo in adults with ADHD, 64% of patients on bupropion showed improvement versus 27% on placebo. Methylphenidate came in at 50%. That said, the difference between the active medications and placebo didn’t reach statistical significance in this particular study, likely due to the small sample size. A meta-analysis looking at children found a larger effect: bupropion produced a meaningful reduction in clinician-rated ADHD symptoms compared to placebo.
Bupropion is often considered when someone has both ADHD and depression, since it can address both conditions with a single medication. It also lacks many of the side effects common to other antidepressants, such as weight gain and sexual dysfunction. It does carry a risk of seizures at higher doses, particularly in people with eating disorders or a seizure history.
Tricyclic Antidepressants
Older tricyclic antidepressants like desipramine and nortriptyline also increase norepinephrine and have been studied for ADHD. Desipramine showed a strong reduction in ADHD symptoms based on teacher ratings in controlled trials, with no serious adverse events reported. These medications take several weeks to reach full effect, unlike stimulants which typically work within hours.
Tricyclics come with notable downsides. Common side effects include drowsiness, dry mouth, and low blood pressure. More concerning, they can affect heart rhythm and require monitoring, especially at higher doses. Nortriptyline doses above 100 mg daily call for blood-level monitoring, and doses beyond 150 mg are not recommended. Because of these cardiovascular risks, tricyclics are generally reserved for cases where other options have failed.
SNRIs and Venlafaxine
Venlafaxine raises both serotonin and norepinephrine and is sometimes tried off-label for ADHD. The evidence supporting it is thinner than for bupropion. Side effects can include nausea, anxiety, sleep problems, tremor, and dry mouth. It’s more commonly used when ADHD coexists with anxiety or depression rather than as a standalone ADHD treatment.
MAOIs
Monoamine oxidase inhibitors increase dopamine, norepinephrine, and serotonin simultaneously, making them theoretically useful for ADHD. In practice, they are rarely prescribed for this purpose because of strict dietary requirements. People taking MAOIs must avoid foods high in tyramine, including aged cheeses, cured meats, draft beer, and other fermented or aged foods. Eating these can trigger dangerously high blood pressure. A skin patch form (selegiline) may allow more dietary flexibility at the lowest dose, but MAOIs remain a last resort for ADHD.
How They Compare to Stimulants
Stimulants remain significantly more effective for core ADHD symptoms. A large network meta-analysis published in The Lancet Psychiatry found that amphetamine-based medications outperformed all other options in adults, with effect sizes ranging from 0.29 to 0.94 standard deviations better than alternatives like atomoxetine. In children and adolescents, the advantage was smaller but still consistent.
To put this in practical terms: stimulants produce noticeable improvements in focus and impulse control for roughly 70 to 80% of people who try them. Antidepressants help a smaller percentage and typically produce more modest improvements. The trade-off is that antidepressants don’t carry the same risks of appetite suppression, insomnia, or potential for misuse that stimulants do. For people who can’t tolerate stimulants or have a history of substance use disorders, antidepressants offer a meaningful alternative even if the ceiling for improvement is lower.
When ADHD and Depression Overlap
Roughly half of adults with ADHD also experience depression or anxiety at some point, which complicates treatment decisions. Current clinical guidelines recommend treating whichever condition is more severe and functionally impairing first. If depression is the bigger problem, stabilizing mood with an antidepressant comes first, followed by reassessing whether ADHD symptoms persist once depression lifts. This sequencing matters because untreated depression can worsen concentration and motivation in ways that mimic or amplify ADHD.
For people dealing with both conditions simultaneously, combining an SSRI or SNRI with a stimulant appears to be both effective and safe. A large observational study of over 17,000 adults with ADHD found that taking an SSRI alongside methylphenidate improved outcomes for both conditions and was actually associated with fewer headaches and tremors than stimulants alone. This combination approach lets each medication target what it does best: the antidepressant handles mood and anxiety, while the stimulant addresses attention and executive function.
One important caveat: antidepressants that primarily raise serotonin (standard SSRIs like fluoxetine and fluvoxamine) have not shown meaningful benefit for ADHD symptoms on their own. Studies testing these medications as standalone ADHD treatments found no significant difference from placebo in reducing core symptoms. They can help with coexisting anxiety or depression, but they won’t fix the attention and organizational difficulties that define ADHD.
What to Expect if You’re Prescribed One
Unlike stimulants, which often work the same day you take them, antidepressants require patience. Most take two to four weeks to reach their full effect on ADHD symptoms. Tricyclics tend to sit at the longer end of that range. Bupropion may show some benefits within the first week or two, but the full picture takes longer to emerge.
Side effect profiles vary by class. Bupropion can cause insomnia, dry mouth, and reduced appetite. Tricyclics tend toward the opposite, causing drowsiness and sometimes weight gain. Venlafaxine splits the difference with sleep disruption and nausea being common early complaints that often settle over time. Your prescriber will typically start at a low dose and increase gradually, both to minimize side effects and to find the lowest effective dose.
If you’re considering this route, the key question to discuss with your prescriber is why an antidepressant over a stimulant or an FDA-approved nonstimulant like atomoxetine. The answer usually involves either a specific side effect concern with stimulants, a coexisting mood disorder, or a history that makes stimulants a poor fit. When those circumstances apply, antidepressants can be a practical and helpful option, even if they’re not the most powerful tool in the ADHD toolkit.